Published in Drug Law Weekly, August 14th, 2007
"A novel class of potential antipsychotics (SSR181507, bifeprunox, and SLV313) possess partial...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.